IRIS
PAPPONE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.817
EU - Europa 8.188
NA - Nord America 6.828
SA - Sud America 2.911
Continente sconosciuto - Info sul continente non disponibili 628
AF - Africa 246
OC - Oceania 6
Totale 27.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.475
RU - Federazione Russa 4.877
SG - Singapore 3.315
CN - Cina 2.517
BR - Brasile 2.364
HK - Hong Kong 1.081
VN - Vietnam 961
SE - Svezia 956
IT - Italia 505
FR - Francia 435
DE - Germania 279
RO - Romania 270
IE - Irlanda 225
FI - Finlandia 204
AR - Argentina 197
IN - India 178
BD - Bangladesh 165
GB - Regno Unito 144
CA - Canada 125
ID - Indonesia 113
MX - Messico 110
EC - Ecuador 93
IQ - Iraq 79
CO - Colombia 75
ZA - Sudafrica 74
AT - Austria 58
TR - Turchia 48
VE - Venezuela 46
PK - Pakistan 45
NL - Olanda 44
PL - Polonia 42
PY - Paraguay 42
JP - Giappone 40
UZ - Uzbekistan 37
MA - Marocco 36
CL - Cile 34
SA - Arabia Saudita 32
UA - Ucraina 26
UY - Uruguay 26
ES - Italia 25
TN - Tunisia 24
DZ - Algeria 22
JM - Giamaica 22
KE - Kenya 22
PH - Filippine 22
LT - Lituania 21
MD - Moldavia 21
NP - Nepal 19
PE - Perù 19
CR - Costa Rica 18
EG - Egitto 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
AZ - Azerbaigian 16
BO - Bolivia 14
DO - Repubblica Dominicana 14
HN - Honduras 14
JO - Giordania 14
OM - Oman 14
KZ - Kazakistan 13
EU - Europa 12
TT - Trinidad e Tobago 10
NI - Nicaragua 9
PT - Portogallo 9
SN - Senegal 9
IR - Iran 8
LB - Libano 8
AL - Albania 7
BE - Belgio 7
ET - Etiopia 7
LY - Libia 6
QA - Qatar 6
SV - El Salvador 6
AM - Armenia 5
BB - Barbados 5
GE - Georgia 5
GT - Guatemala 5
KW - Kuwait 5
NG - Nigeria 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
BZ - Belize 4
KR - Corea 4
XK - ???statistics.table.value.countryCode.XK??? 4
AU - Australia 3
BG - Bulgaria 3
CD - Congo 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
NO - Norvegia 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
Totale 26.958
Salva come PNG Salva come JPEG
Città #
Dallas 2.243
Singapore 1.255
Hong Kong 1.069
Moscow 1.018
San Jose 623
Ashburn 617
Shanghai 473
Hefei 459
Lawrence 429
Princeton 427
Ho Chi Minh City 394
Lauterbourg 386
Dublin 225
Hanoi 189
São Paulo 188
Helsinki 171
Beijing 169
New York 154
Milan 135
Santa Clara 129
Los Angeles 90
Rio de Janeiro 73
Nuremberg 64
Orem 62
Boardman 53
Brasília 44
Curitiba 44
Belo Horizonte 42
Da Nang 42
Haiphong 42
Munich 42
Chennai 40
Rome 39
Porto Alegre 38
Johannesburg 37
Warsaw 37
Denver 34
Guangzhou 34
Atlanta 33
Brooklyn 33
Chicago 33
Tashkent 33
Tianjin 33
Tokyo 33
London 32
Salvador 32
Baghdad 31
Frankfurt am Main 31
Guayaquil 31
Seattle 31
Toronto 31
Boston 30
Campinas 28
Phoenix 28
Manchester 27
Stockholm 26
Pune 25
Vienna 25
Biên Hòa 24
Council Bluffs 24
Quito 24
Washington 24
Amsterdam 23
Hangzhou 23
Poplar 23
Montreal 22
Houston 21
Montevideo 21
Buenos Aires 20
Jakarta 20
Nairobi 20
Asunción 19
Caxias do Sul 19
Goiânia 19
San Francisco 19
Santo André 19
Dhaka 18
Guarulhos 18
Hải Dương 18
Las Vegas 18
Mumbai 18
Osasco 18
Ribeirão Preto 18
Caracas 17
Mexico City 17
Recife 17
Thái Nguyên 17
Ankara 16
Fortaleza 16
Lappeenranta 16
Shenzhen 16
Sorocaba 16
Turku 16
Baku 15
Bogotá 15
Jeddah 15
Lahore 15
Medellín 15
Amman 14
Aracaju 14
Totale 12.993
Salva come PNG Salva come JPEG
Nome #
1. Cardiac Resynchronization Therapy with Multisite Left Ventricular Pacing Improves Acute Hemodynamic Response in Patients 1.425
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 232
A 20-joule electrical cardioversion applied directly to the heart elevates troponin I by at least 1.5 ng.mL(-1) 146
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 137
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 136
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 133
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society 131
A controlled randomized trial of biatrial ablation for curing long-lasting permanent atrial fibrillation (the Decomplex Trial) 130
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 128
Ablation catheter with flexible tip and methods of making the same 127
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 126
65. Cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure early multicenter experience 125
Brugada syndrome genetics is associated with phenotype severity 123
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 119
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 119
A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White Syndrome 117
A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach 116
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 114
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 111
[A methodological approach to the transcatheter radiofrequency ablation of anomalous Kent-type pathways] 111
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 110
[The physical and chemical principles of radiofrequency catheter ablation in arrhythmias] 109
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 107
[Atrioventricular conduction before and after the radiofrequency catheter ablation of a nodal reentry tachycardia circuit] 105
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 105
[Ablation of paroxysmal tachycardia in Wolff-Parkinson-White syndrome] 104
Brugada Syndrome: Warning of a Systemic Condition? 103
“Cardiac Resynchronization Therapy” 102
“How to Perform Circumferential Pulmonary Vein Ablation with Electroanatomical Guidance” 101
“How to implant biventricular pacemakers in patients with heart failure” (basics and advanced techniques 101
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study 100
A randomized study of prophyl actic catheter ablation in high-risk children with asymptomatic Wolff-Parkinson-White syndrome 100
“Theory and Practice of Catheter Ablation of Atrial Fibrillation. Seven different cases” 99
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 99
[Radiofrequency catheter ablation of atrial tachycardia: technique, results and follow-up] 98
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 97
[Prospects of the treatment of atrial fibrillation. Circumferential radiofrequency ablation of pulmonary vein ostia] 97
Calcium in Brugada syndrome: Questions for future research 96
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 95
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 95
HIF-1α Directly Controls WNT7A Expression During Myogenesis 95
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 93
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 92
“Stroke Prevention: Left Atrial Appendage Occlusion” 91
The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction 91
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate 90
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 87
Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation 87
Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study 87
“Circumferential Pulmonary Vein Ablation With MediGuide® System” 86
“Management of Advanced Atrial Fibrillation” 85
Course Syllabus: “Theory and Practice of Catheter Ablation of Atrial Fibrillation 2002” 84
Brugada Syndrome: Oligogenic or Mendelian Disease? 84
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 82
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 82
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Meta-Analysis of Quality of Life, Morbidity, and Mortality 82
Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis 80
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis 79
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 79
Stereotaxis “Atrial Fibrillation Ablation” 79
Antitachycardia devices for the treatment of recurrent ventricular tachycardia: long term results 79
Follow-up of a respiratory rate modulated pacemaker 79
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 79
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA) 78
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 78
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 78
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation 77
The APAF study: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial [Die APAF-studie: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial] 77
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 77
Management of severe cardiac arrhythmic events in elite athletes 76
Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: A multicentre registry 75
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 74
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 74
Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion injury 74
Novel JAG1 deletion variant in patient with atypical alagille syndrome 74
Atrial fibrillation progression and management: a 5-year prospective follow-up study 73
Prospective European survey on atrial fibrillation ablation: Clinical characteristics of patients and ablation strategies used in different countries 73
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 72
Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram 72
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 72
Deep learning unmasks the ECG signature of Brugada syndrome 70
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 70
Regenerating the human heart : direct reprogramming strategies and their current limitations 70
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 70
Quantitative assessment of left ventricular contractile synchrony during biventricular pacing using color kinesis echocardiography 70
Nanobodies Counteract the Toxicity an Amyloidogenic Light Chain by Stabilizing a Partially Open Dimeric Conformation 69
Primary atrial tachycardia: techniques for intracardiac mapping and radiofrequency ablation 69
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 69
Cardiac magnetic resonance with implanted monitor 69
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 69
Atrial fibrillation in elite athletes 68
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 68
Circumferential pulmonary-vein ablation for chronic atrial fibrillation 67
Wolff-parkinson-white syndrome in the era of catheter ablation insights from a registry study of 2169 patients 66
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 66
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 65
Fibroma of the left ventricle in a patient with Sotos syndrome 65
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 65
Epicardial ablation of atrial fibrillation during heart valve surgery 64
Efficacy of radiofrequency catheter ablation of accessory pathway in patients with previous unsuccessful surgical ablation 64
Totale 10.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 0 0 90 8 9 19 3 22 2 13 7
2022/20232.257 1.071 444 106 18 6 180 223 76 83 32 14 4
2023/2024563 39 23 59 78 39 69 14 57 0 28 38 119
2024/20255.661 834 79 26 77 121 387 824 454 1.149 896 373 441
2025/202617.981 1.066 1.662 2.525 2.910 1.037 476 1.274 1.081 4.313 968 365 304
2026/2027562 543 19 0 0 0 0 0 0 0 0 0 0
Totale 27.624